SpringWorks Therapeutics Announces PDUFA Date Extension for

FDA Extending PDUFA Date by Three Months to Allow More Time to Complete Their Review; New PDUFA Date Set to November 27, 2023STAMFORD, Conn., June 05, 2023 -- SpringWorks Therapeutics, Inc. , a... | June 5, 2023

Related Keywords

Denmark , France , United States , Coindre , Auvergne , Samantha Hilson Sandler , Saqib Islam , Bone Sarcoma Group , European Medicines Agency , Desmoid Working Group , Springworks Therapeutics Inc , Desmoid Tumor Working Group , European Organization For Research , Linkedin , Drug Administration , European Commission , Nasdaq , Twitter , European Consensus Initiative , Three Months , Allow More Time , Complete Their Review , Works Therapeutics , Prescription Drug User Fee Act , New Drug Application , Major Amendment , Chief Executive Officer , Priority Review , Time Oncology Review , New England Journal , Breakthrough Therapy , Fast Track , Orphan Drug , Marketing Authorization Application , Response Evaluation Criteria , Solid Tumors , Breakthrough Therapy Designations , Orphan Drug Designation , Private Securities Litigation Reform Act , Springwork Quarterly Report , Gamma Secretase Inhibitor , Desmoid Working , European Organization , Soft Tissue , Mayo Clinic , Desmoid Tumors , Report Series , Rare Diseases , Desmoid Tumor Working , Springworks Therapeutics , Nc Stock Exchange , News , Information , Press Release , Fda , Xtending , Pdufa , Gate , Y , Three , Months , O , Follow , More , Dime , Omplete , Their , Few , Pet , November , Pune , 023 , Pringworks Swtx Us85205l1070 ,